Geode Capital Management, LLC Revolution Medicines, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,627,025 shares of RVMD stock, worth $157 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,627,025
Previous 3,335,656 8.73%
Holding current value
$157 Million
Previous $129 Million 26.95%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$36.92 - $47.94 $10.8 Million - $14 Million
291,369 Added 8.73%
3,627,025 $164 Million
Q2 2024

Aug 09, 2024
BUY
$30.14 - $40.68 $8.53 Million - $11.5 Million
282,965 Added 9.27%
3,335,656 $129 Million
Q1 2024

May 13, 2024
BUY
$26.56 - $33.55 $1.96 Million - $2.48 Million
73,907 Added 2.48%
3,052,691 $98.4 Million
Q4 2023

Feb 13, 2024
BUY
$18.35 - $34.12 $16.6 Million - $30.9 Million
906,052 Added 43.71%
2,978,784 $85.4 Million
Q3 2023

Nov 13, 2023
BUY
$25.17 - $35.05 $3.13 Million - $4.36 Million
124,272 Added 6.38%
2,072,732 $57.4 Million
Q2 2023

Aug 11, 2023
BUY
$20.28 - $27.0 $4.35 Million - $5.79 Million
214,383 Added 12.36%
1,948,460 $52.1 Million
Q1 2023

May 15, 2023
BUY
$20.76 - $30.09 $5.96 Million - $8.64 Million
287,221 Added 19.85%
1,734,077 $37.6 Million
Q4 2022

Feb 13, 2023
BUY
$17.68 - $25.53 $1.21 Million - $1.74 Million
68,304 Added 4.95%
1,446,856 $34.5 Million
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $3.72 Million - $5.53 Million
212,794 Added 18.25%
1,378,552 $27.2 Million
Q2 2022

Aug 12, 2022
BUY
$14.54 - $27.17 $651,639 - $1.22 Million
44,817 Added 4.0%
1,165,758 $22.7 Million
Q1 2022

May 13, 2022
BUY
$17.31 - $26.4 $301,955 - $460,521
17,444 Added 1.58%
1,120,941 $28.6 Million
Q4 2021

Feb 11, 2022
BUY
$24.35 - $33.7 $549,287 - $760,204
22,558 Added 2.09%
1,103,497 $27.8 Million
Q3 2021

Nov 12, 2021
BUY
$23.95 - $33.41 $3.28 Million - $4.57 Million
136,881 Added 14.5%
1,080,939 $29.7 Million
Q2 2021

Aug 13, 2021
BUY
$29.0 - $47.44 $4.8 Million - $7.85 Million
165,458 Added 21.25%
944,058 $30 Million
Q1 2021

May 12, 2021
BUY
$37.21 - $54.43 $5.07 Million - $7.42 Million
136,235 Added 21.21%
778,600 $35.7 Million
Q4 2020

Feb 12, 2021
BUY
$30.19 - $45.49 $491,040 - $739,894
16,265 Added 2.6%
642,365 $25.4 Million
Q3 2020

Nov 13, 2020
BUY
$22.61 - $34.8 $8.39 Million - $12.9 Million
370,940 Added 145.38%
626,100 $21.8 Million
Q2 2020

Aug 13, 2020
BUY
$19.65 - $39.34 $2.64 Million - $5.28 Million
134,282 Added 111.09%
255,160 $8.06 Million
Q1 2020

May 14, 2020
BUY
$20.0 - $34.08 $2.42 Million - $4.12 Million
120,878 New
120,878 $2.65 Million

Others Institutions Holding RVMD

# of Institutions
266
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email